To further investigate the antifibrotic action of sh-lnc-PCF in vivo, we tested the expression levels of E-cadherin, SP-C, α-SMA, collagen III, and vimentin, which are indicators of pulmonary fibrosis, after sh-lnc-PCF spraying in vivo. Here, ACTA1 is linked to pulmonary fibrosis.